Khalid Azalmad
Papers
1
Total Citations
4
H-Index
1
About
Khalid Azalmad is a surgical oncologist whose research centers on the treatment of head and neck cancers, with a particular focus on transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. His major contribution lies in clarifying the role of TORS specifically for HPV-negative oropharyngeal cancers—a patient population that has been historically underrepresented in robotic surgery literature. In his landmark 2024 study, Azalmad conducted a retrospective analysis of 37 patients, providing critical follow-up data on both oncological and functional outcomes. This work addresses a significant gap in evidence, demonstrating that TORS can be an effective treatment modality even for HPV-negative disease, which typically carries a worse prognosis. With 4 citations already, this paper is gaining traction as a foundational reference for surgeons managing this challenging patient group. Azalmad’s research is notable for its focus on real-world outcomes and its potential to expand the indications for robotic surgery, ultimately helping to personalize treatment strategies for oropharyngeal cancer patients.
Research Focus
Key Achievements
Top Papers
- 1